Recent posts and comments

• PerkinElmer Buys Gas Analyzer Firm

  PerkinElmer (NYSE:PKI), a Waltham, MA-based provider of products and services in the health-care, analytical sciences and photonics industries, announced it has acquired gas analyzer supplier Arnel, headquartered in Parlin,... Read more »

• Harvard Endowment Down $8B, Further Losses Expected

  Harvard University’s endowment, the largest in higher education and historically a major investor in venture capital funds, has dropped a scary 22 percent, or $8 billion, from its $36.9 billion value... Read more »

• Artes Files for Bankruptcy After Drop in Facial Filler Sales

  Artes Medical, a maker of an injectable filler to smooth facial wrinkles, has filed for Chapter 7 bankruptcy, citing reduced consumer spending on its cosmetic treatment due to the poor... Read more »

• Vestas Wind Picks Mass. R&D Site

  Vestas Wind Systems, a Danish wind turbine maker, reports that it plans to open an R&D center at an undisclosed location in the western suburbs of Boston, where it will develop... Read more »

• Venom-Derived Drug Trial Gets FDA OK

  Transmolecular, a Cambridge, MA-based biotech firm, reports that the FDA has agreed to consider a filing for approval of its lead anti-cancer drug (TM601) if the molecule meets goals of a... Read more »

• Biogen Confirms HQ Move from Cambridge to Suburbs

  Biogen Idec (NASDAQ:BIIB) confirmed yesterday that the biotech company plans to move its corporate headquarters from Cambridge, MA, to a site in Weston, MA, in 2010, the Boston Business... Read more »

• Boston Scientific in $11M Funding for Estech

  Natick, MA-based medical devices giant Boston Scientific (NYSE:BSX) has invested in an $11 million closing of a second-round financing for Endoscopic Technologies (Estech), a privately held provider of minimally... Read more »

• Hospital-Backed Partners VC Fund Finds Deals Close to Home—Here’s the Early List

  It occurred to me that Partners Innovation Fund, unlike all other venture investors I can think of, knows exactly where it will find its future deals. That’s because the fund, launched... Read more »

• Having Vanquished Hair Frizz, Living Proof Looks to Skin Care and Cosmetics

  Since I wrote about Living Proof this summer, we’ve had a flurry of comments and questions about the Cambridge, MA-based firm’s biotech-inspired products for combating frizzy hair. And my Xconomy colleagues... Read more »

• Nuance Makes New Bid for Zi

  Nuance Communications (NASDAQ:NUAN), the Burlington, MA-based speech recognition powerhouse, today announced an offer to buy Zi Corporation (NASDAQ:ZICA), a Calgary, Canada-based provider of software to speed text... Read more »

• Awarepoint Tracks Down $13.3M to Fuel Hospital RFID Business

  Awarepoint says it has raised $13.3 million in a Series D round of financing from a trio of private equity investors—who are betting hospitals will continue to invest in RFID systems... Read more »

• Mobui Behind TiVo Mobile Application

  Mobui, a Redmond, WA-based mobile applications firm, and TiVo (NASDAQ:TIVO), headquartered in Alvisto, CA, have announced that the two firms developed a new Web site that enables TiVo subscribers... Read more »

• Ambient Raises $8M from Vicis

  Ambient (OTC:ABTG), a Newton, MA-based provider of software and services to help electrical utilities use existing power lines to deliver IP-based services, reports it has raised $8 million from... Read more »

• Panacos to Repay $20M Loan

  Panacos Pharmaceuticals (NASDAQ:PANC), a Watertown, MA-based developer of antiviral drugs for HIV, says that it has agreed to repay $17.9 million in outstanding principal, interest, and fees on a... Read more »

• New $50M Medtech Fund Launched

  Yankee Equity Solution, a private equity firm, has launched a $50 million fund to invest in medtech outfits in the Boston area, according to a company statement. The new YES... Read more »

• Adimab Closes Third VC Round

  Adimab, a Lebanon, NH-based biotech firm focused antibody discovery, says it has closed a Series C round of financing from new investors OrbiMed Advisors, Borealis Ventures, and return backers Polaris Venture... Read more »

• Radius Adds $15M to Series C

  Radius Health, a Cambridge, MA-based developer of drugs for osteoporosis and women’s health, says it has added $15 million more to its Series C round of venture capital, which now totals... Read more »

• Staccato Marries Artimi, Gets $20M Burst

  Will it be a match made in ultra wideband heaven? San Diego-based Staccato Communications says it has merged with another ultra wideband semiconductor developer, Artimi, and raised $20 million in equity... Read more »

• Idera and Merck Extend R&D Deal

  Idera Pharmaceuticals (NASDAQ:IDRA), a Cambridge, MA-based developer of drugs that target a family of immune system receptors, reports it has inked a one-year extension to its research collaboration with... Read more »

• Got Dry Eye? Take Fish Oil. Resolvyx Moves First Compound Into Human Test

  Resolvyx Pharmaceuticals is eying the ophthalmic market. The Bedford, MA-based biotech firm plans to announce today that the first human clinical tests of its resolvins—compounds with anti-inflammatory properties that occur naturally... Read more »